Product Program year 2021 Source: CMS Open Payments

RNS System

Device Epilepsy

PDI 00855547005267

Open in the dashboard

General payments

$107,659

400 payments

Research payments

$450,507

2,434 payments

Through program year 2021, $107,659 in general payments and $450,507 in research payments were reported against RNS System (Epilepsy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $107,659 400
2021 Research $450,507 2,434

Breakdown

Who paid General payments · program year 2021
  1. NeuroPace, Inc. $107,659 400 payments
Top recipients General payments · program year 2021
  1. Vikram Rao Neurology · San Francisco, CA $19,543 18% · 19 payments
  2. David Burdette Epilepsy · Grand Rapids, MI $14,582 14% · 29 payments
  3. Patricia Dugan Epilepsy · New York, NY $10,014 9% · 12 payments
  4. Danielle Becker Epilepsy · Columbus, OH $9,708 9% · 16 payments
  5. Fedor Panov Neurological Surgery · New York, NY $5,690 5% · 10 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Epilepsy Psychiatry & Neurology $44,241 41% · 27 practitioners
  2. Neurology Psychiatry & Neurology $40,001 37% · 67 practitioners
  3. Neurological Surgery $19,177 18% · 30 practitioners
  4. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $2,924 3% · 21 practitioners
  5. Clinical Neurophysiology Psychiatry & Neurology $926 <1% · 7 practitioners

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. California $27,850 26% · 31 recipients
  2. Michigan $19,475 18% · 12 recipients
  3. New York $17,617 16% · 13 recipients
  4. Pennsylvania $14,988 14% · 8 recipients
  5. Utah $5,196 5% · 2 recipients

The top 5 of 30 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

400 general · 2,434 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record